3 Profitable Stocks to Keep an Eye On

via StockStory
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

UNH Cover Image

Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

Identifying the most compelling profitable companies isn’t always straightforward, and that’s why we started StockStory. That said, here are three profitable companies that leverage their financial strength to beat the competition.

UnitedHealth (UNH)

Trailing 12-Month GAAP Operating Margin: 4.8%

With over 100 million people served across its various businesses and a workforce of more than 400,000, UnitedHealth Group (NYSE:UNH) operates a health insurance business and Optum, a healthcare services division that provides everything from pharmacy benefits to primary care.

Why Do We Like UNH?

  1. Annual revenue growth of 10.6% over the last five years was above the sector average and underscores its products and services value to customers
  2. Unparalleled scale of $450.1 billion in revenue enables it to spread administrative costs across a larger membership base
  3. Industry-leading 19.2% return on capital demonstrates management’s skill in finding high-return investments

UnitedHealth is trading at $387.78 per share, or 18.5x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Elevance Health (ELV)

Trailing 12-Month GAAP Operating Margin: 3.8%

Formerly known as Anthem until its 2022 rebranding, Elevance Health (NYSE:ELV) is one of America's largest health insurers, serving approximately 47 million medical members through its network-based managed care plans.

Why Are We Positive on ELV?

  1. Massive revenue base of $198.7 billion gives it meaningful leverage when negotiating reimbursement rates
  2. Earnings growth has topped the peer group average over the last five years as its EPS has compounded at 7.2% annually
  3. Industry-leading 26% return on capital demonstrates management’s skill in finding high-return investments

Elevance Health’s stock price of $418.57 implies a valuation ratio of 14.6x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free.

Texas Pacific Land (TPL)

Trailing 12-Month GAAP Operating Margin: 74.9%

One of America's largest private landowners with roughly 868,000 acres in the Permian Basin, Texas Pacific Land (NYSE:TPL) owns land in West Texas and earns revenue from oil and gas royalties, water services, and land leases.

Why Will TPL Beat the Market?

  1. Market share has increased this cycle as its 31.1% annual revenue growth over the last ten years was exceptional
  2. Attractive asset base leads to wonderful unit economics and a best-in-class gross margin of 94.9%
  3. Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends

At $367.72 per share, Texas Pacific Land trades at 27.5x forward EV-to-EBITDA. Is now a good time to buy? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article